AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitatrack M 50/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Meraki Health

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Sitatrack M 50/1000 Tablet

Duo-Med 50/1000 tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent serious diabetic complications like vision loss and kidney impairment, potentially lowering heart attack and stroke risk. Duo-Med 50/1000 may be used independently or with other diabetes treatments. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and other medications. Consuming the tablets with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinue only under your doctor's guidance. Adherence to your prescribed diet and exercise plan is crucial. Lifestyle significantly influences diabetes control. Common side effects include nausea, diarrhea, vomiting, indigestion, headache, and sore throat. Low blood sugar (hypoglycemia) is a potential side effect, especially when combined with insulin or sulfonylureas; learn to identify and manage this. This medication isn't suitable for all individuals. Inform your physician of any pre-existing kidney, liver, heart, or pancreatic conditions, or excessive alcohol consumption before starting treatment. Pregnant or breastfeeding individuals should consult their doctor. Interactions with other medications are possible; disclose all medications to your doctor. Alcohol should be minimized due to its blood glucose-lowering effect. Your doctor will monitor your kidney function and blood glucose levels throughout treatment.

Uses of Sitatrack M 50/1000 Tablet

Managing Type 2 Diabetes

Major Benefits of Sitatrack M 50/1000 Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sitatrack M 50/1000 should be administered with a meal.

Common Side effects of Sitatrack M 50/1000 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitatrack M 50/1000 Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sitatrack M 50/1000 Tablet with a meal.

How Sitatrack M 50/1000 Tablet works:

Sitatrack M 50/1000 tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin boosts insulin production from the pancreas, improves insulin utilization, and lessens the liver's glucose output. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. This dual action leads to superior blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol ingestion and Sitatrack M 50/1000 Tablet use poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitatrack M 50/1000 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Lactation and Sitatrack M 50/1000 tablets are likely incompatible. Preliminary human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Sitatrack M 50/1000 tablets, as dosage modification may be necessary. Consult a physician before use. Sitatrack M 50/1000 tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Sitatrack M 50/1000 Tablets is likely contraindicated in individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitatrack M 50/1000 Tablet :

Should you forget a Sitatrack M 50/1000 Tablet dose, take it promptly. If, however, your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Sitatrack M 50/1000 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitatrack M 50/1000 Tablet

Sitatrack M 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sitatrack M 50/1000 tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitatrack M 50/1000 Tablet may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Sitatrack M 50/1000 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitatrack M 50/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin + Metformin (like Sitatrack M 50/1000) can rarely cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This risk is increased in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sitatrack M 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitatrack M 50/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitatrack M 50/1000 Tablet is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitatrack M 50/1000 tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin (like Sitatrack M 50/1000) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA – Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitatrack M 50/1000 Tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary difficulties, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Sitatrack M 50/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitatrack M 50/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitatrack M 50/1000 Tablets are contraindicated in patients with known allergies to any component or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitatrack M 50/1000 tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Sitagliptin + Metformin (like Sitatrack M 50/1000) can, rarely, cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This risk is heightened in patients with kidney disease, older adults, and heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Sitatrack M 50/1000 Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitatrack M 50/1000 Table...
161
MRP 187
13% off